Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

US Patent 10738075 · Granted Aug 11, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Longer-acting progestin prodrug contraceptives2020
Longer-acting progestin prodrug contraceptives2020
Pro-drug forming compounds2019
Pro-drug forming compounds2019
Pro-drug forming compounds2019
Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for2018
Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for2018
Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for2018
Combination of estrogens plus antiprogestins with significant partial agonistic 2017
Combination of estrogens plus antiprogestins with significant partial agonistic 2017
Combination of estrogens plus antiprogestins with significant partial agonistic 2017
Pro-drug forming compounds2017